- - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...
- Phase I Data for NKP-1339, a First-in-Class Transferrin Targeted Anti-Cancer Agent to be Presented at Upcoming ...
Professor Ian Frazer, creator of the HPV vaccine against cervical cancer will visit Indonesia from 25 to 28 April ...
- Berg Diagnostics, a member of the Berg Pharma, Inc group of companies with Berg ...
- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg ...
- - First Presentations of European-Australian and North American Phase III Trials ...
- Broadens later stage capabilities and Increases Asian ...